JP Morgan Chase
JBIO icon

JP Morgan Chase’s Jade Biosciences JBIO Stock Holding History

JP Morgan Chase’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.8M Sell
1,469,144
-5,935
-0.4% -$119K ﹤0.01% 2180
2026
Q2 		$32.6M Buy
1,475,079
+1,459,216
+9,199% +$30.4M ﹤0.01% 1811
2026
Q1 		$210K Sell
15,863
-4,736
-23% -$68.6K ﹤0.01% 5445
2025
Q4 		$318K Buy
20,599
+7,401
+56% +$86.8K ﹤0.01% 5282
2025
Q3 		$114K Sell
13,198
-2,169
-14% -$17.7K ﹤0.01% 5830
2025
Q2 		$154K Buy
15,367
+13,205
+611% +$449K ﹤0.01% 5379
2025
Q1 		$190K Buy
2,162
+243
+13% +$21.3K ﹤0.01% 5263
2024
Q4 		$178K Buy
1,919
+1,748
+1,022% +$151K ﹤0.01% 5527
2024
Q3 		$12.5K Buy
171
+5
+3% +$323 ﹤0.01% 6328
2024
Q2 		$9.7K Buy
166
+35
+27% +$23.2K ﹤0.01% 6272
2024
Q1 		$136K Sell
131
-83
-39% -$63.4K ﹤0.01% 5539
2023
Q4 		$169K Buy
214
+2
+0.9% +$1.02K ﹤0.01% 5483
2023
Q3 		$101K Sell
212
-19
-8% -$10.3K ﹤0.01% 5466
2023
Q2 		$138K Buy
231
+29
+14% +$18.5K ﹤0.01% 5296
2023
Q1 		$143K Buy
202
+52
+35% +$43.1K ﹤0.01% 5260
2022
Q4 		$154K Sell
150
-45
-23% -$32.7K ﹤0.01% 5165
2022
Q3 		$113K Buy
195
+27
+16% +$18K ﹤0.01% 5230
2022
Q2 		$92K Sell
168
-89
-35% -$42.5K ﹤0.01% 5450
2022
Q1 		$165K Buy
257
+85
+49% +$33K ﹤0.01% 5287
2021
Q4 		$71K Buy
172
+22
+15% +$11.1K ﹤0.01% 5813
2021
Q3 		$110K Buy
+150
New +$84K ﹤0.01% 5518

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

JP Morgan Chase's JBIO Position: Q3 2026 in Review

JP Morgan Chase reduced its Jade Biosciences (JBIO) stake by 0.4% in Q3 2026, selling an estimated $119K and leaving 1,469,144 shares worth $20.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

JP Morgan Chase first reported a position in JBIO in Q3 2021 and has held it in 21 quarters since. The position peaked at $32.6M in Q2 2026. 70 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • JP Morgan Chase held 1,469,144 shares of Jade Biosciences worth $20.8M as of Q3 2026.
  • JP Morgan Chase sold 5,935 Jade Biosciences shares in Q3 2026, an estimated $119K.
  • Jade Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #2180 holding.
  • JP Morgan Chase first reported a position in Jade Biosciences in Q3 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Jade Biosciences position peaked at $32.6M in Q2 2026.
  • 70 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.